These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 28222786)
1. Post translational modification of Parkin. Chakraborty J; Basso V; Ziviani E Biol Direct; 2017 Feb; 12(1):6. PubMed ID: 28222786 [TBL] [Abstract][Full Text] [Related]
2. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin. Hristova VA; Beasley SA; Rylett RJ; Shaw GS J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245 [TBL] [Abstract][Full Text] [Related]
3. Post-translational modification of Parkin and its research progress in cancer. Ding D; Ao X; Liu Y; Wang YY; Fa HG; Wang MY; He YQ; Wang JX Cancer Commun (Lond); 2019 Nov; 39(1):77. PubMed ID: 31753025 [TBL] [Abstract][Full Text] [Related]
4. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications. Durcan TM; Fon EA Genes Dev; 2015 May; 29(10):989-99. PubMed ID: 25995186 [TBL] [Abstract][Full Text] [Related]
5. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitin phosphorylated at Ser57 hyper-activates parkin. George S; Wang SM; Bi Y; Treidlinger M; Barber KR; Shaw GS; O'Donoghue P Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):3038-3046. PubMed ID: 28689991 [TBL] [Abstract][Full Text] [Related]
7. Phospho-ubiquitin: upending the PINK-Parkin-ubiquitin cascade. Matsuda N J Biochem; 2016 Apr; 159(4):379-85. PubMed ID: 26839319 [TBL] [Abstract][Full Text] [Related]